Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea - Reuters

Reuters | Dec. 20, 2024, 5:23 p.m. | Original
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea Reuters
US finalizes up to $6.75 billion in chips awards for Samsung, Texas Instruments, Amkor - Reuters Rumble to receive $775 million strategic investment from Tether - Reuters.com